Gaku Yamamichi Selected Research

Gaku Yamamichi Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 01/2018
10	Carcinoma (Carcinomatosis) 12/2022 - 02/2016
7	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2020
6	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 07/2019
4	Urinary Bladder Neoplasms (Bladder Cancer) 05/2023 - 01/2019
2	Disease Progression 12/2022 - 01/2021
2	Infections 01/2017 - 08/2016
1	Lymphatic Metastasis 03/2023
1	Dysbiosis 01/2022
1	Inflammation (Inflammations) 01/2021
1	Proteinuria 09/2020
1	Seminoma 02/2020
1	Testicular Neoplasms (Testicular Cancer) 02/2020
1	Fused Kidney 07/2019
1	Diabetes Mellitus 01/2019
1	Urinary Retention 01/2019
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2019
1	Aneurysm (Aneurysms) 02/2018
1	Tuberous Sclerosis (Bourneville's Disease) 02/2018
1	Angiomyolipoma 02/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	IgA Deficiency 01/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Ichthyosis (Xeroderma) 11/2016
1	Pyelonephritis 08/2016
1	Necrosis 08/2016
1	Inguinal Hernia (Direct Inguinal Hernia) 07/2016
1	Foreign Bodies (Foreign Body) 03/2016

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2017
5	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2021
3	AcidsIBA 11/2020 - 09/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024 - 10/2022
2	Circulating Tumor DNAIBA 05/2022 - 01/2022
2	Cell-Free Nucleic AcidsIBA 05/2022 - 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 03/2024
1	AntigensIBA 03/2024
1	Radioisotopes (Radionuclides)IBA 03/2024
1	Poly Adenosine Diphosphate RiboseIBA 03/2024
1	Bacterial DNAIBA 09/2023
1	enzalutamideIBA 03/2023
1	Therapeutic UsesIBA 03/2023
1	Tartrate-Resistant Acid PhosphataseIBA 01/2023
1	pembrolizumabIBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	EphrinsIBA 10/2022
1	EnzymesIBA 10/2022
1	ImmunosorbentsIBA 10/2022
1	fexofenadine (Allegra)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	NivolumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	NucleotidesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Histamine H1 AntagonistsIBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	lardIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Amino Acids FDA Link 11/2020
1	Aminolevulinic Acid (Levulan)FDA Link 11/2020
1	protoporphyrin IXIBA 11/2020
1	Sunitinib (Sutent)FDA Link 09/2020
1	Tyrosine Kinase InhibitorsIBA 09/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2020
1	SodiumIBA 01/2019
1	trans-sodium crocetinate (crocetin)IBA 02/2018
1	anti-IgAIBA 01/2017
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 11/2016

Therapy/Procedure

7	Therapeutics 03/2024 - 08/2016
3	Nephroureterectomy 03/2020 - 02/2016
3	Orchiectomy (Orchidectomy) 02/2020 - 07/2016
3	Nephrectomy 07/2019 - 08/2016
2	Castration 03/2024 - 03/2023
2	Cystectomy 05/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2023 - 05/2022
1	Radiotherapy 05/2023
1	Neoadjuvant Therapy 05/2023
1	Urinary Diversion (Ileal Conduit) 05/2023
1	Immunotherapy 12/2022
1	Induction Chemotherapy 11/2022
1	Maintenance Chemotherapy 11/2022
1	Intravesical Administration 04/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Oral Administration 01/2021
1	Urinary Catheters 01/2019
1	Ligation 01/2018
1	Plasmapheresis 01/2017
1	Plasma Exchange 01/2017
1	Transplantation 01/2017
1	Renal Dialysis (Hemodialysis) 01/2017
1	Kidney Transplantation 01/2017
1	Catheters 01/2017
1	Length of Stay 08/2016
1	Cystotomy 03/2016